Oral implications of polypharmacy in the elderly

Dental Clinics of North America

Volumn 58, Issue 4, 2014, Pages 783-796

  Singh, Mabi L ^a   Papas, Athena ^a  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Elderly; Medications; Polypharmacy; Saliva; Salivary hypofunction

Indexed keywords

ADVERSE DRUG REACTION; AGED; CHEMICALLY INDUCED; DENTAL PROCEDURE; DRUG EFFECTS; HOMEOSTASIS; HUMAN; MOUTH DISEASES; POLYPHARMACY; QUALITY OF LIFE; SALIVA; TOOTH DISEASES; XEROSTOMIA;

AGED; DENTAL CARE FOR AGED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOMEOSTASIS; HUMANS; MOUTH DISEASES; POLYPHARMACY; QUALITY OF LIFE; SALIVA; TOOTH DISEASES; XEROSTOMIA;

EID: 84908207652     PISSN: 00118532     EISSN: 15580512     Source Type: Journal    
DOI: 10.1016/j.cden.2014.07.004     Document Type: Review

References (46)

1. US Department of Health and Human Services. Centers for Disease Control and Prevention. Health, United States, 2012. With special feature on emergency care. Available at: . Accessed December 16, 2013. http://www.cdc.gov/nchs/data/hus/hus12.pdf#018.
2. US Census Bureau, Population division percent distribution of the projected population by selected age groups and sex for the United States: 2015 to 2060. 2012. Available at: . Accessed January 1, 2014. http://www.census.gov/population/projections/data/national/2012/summarytables.html.
3. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009, 41(2):67-76. 10.1080/03602530902722679.
4. Mangoni A.A., Jackson S.H. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004, 57(1):6-14. 10.1046/j.1365-2125.2003.02007.x.
5. Vered M., Buchner A., Boldon P., et al. Age-related histomorphometric changes in labial salivary glands with special reference to the acinar component. Exp Gerontol 2000, 35(8):1075-1084.
6. Baum B.J. Evaluation of stimulated parotid saliva flow rate in different age groups. JDent Res 1981, 60:1292-1296.
7. Nagler R.M., Hershkovich O. Age-related changes in unstimulated salivary function and composition and its relations to medications and oral sensorial complaints. Aging Clin Exp Res 2005, 17(5):358-366.
8. Centers for Disease Control and Prevention. Prescription drug use continues to increase: US prescription drug data for 2007-2008. Available at: . Accessed January 1, 2014. http://www.cdc.gov/nchs/data/databriefs/db42.htm.
9. Farley D. Label literacy for OTC drugs. FDA Consum 1997, 31(4):6-11.
10. Glaser J., Rolita L. Educating the older adult in over-the-counter medication use. Geriatr Aging 2009, 12(2):103-109.
11. Qato D.M., Alexander G., Conti R.M., et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008, 300(24):2867-2878. 10.1001/jama.2008.892.
12. Yuan-Pang W., Andrade L.H. Epidemiology of alcohol and drug use in the elderly. Curr Opin Psychiatry 2013, 26(4):343-348.
13. Feinberg M. The problems of anticholinergic adverse effects of medication in elderly. Arch Intern Med 1993, 3:335-348.
14. Mintzer J., Burns A. Anticholinergic side-effects of drugs in elderly people. JR Soc Med 2000, 93:457-462.
15. Available at: . Accessed January 1, 2014. http://drymouth.info/practitioner/overview.asp.
16. Lambert D.G., Appadu B.L. Muscarinic receptor subtypes: do they have a place in clinical anesthesia. Br J Anaesth 1995, 74:497-499.
17. Available at: . Accessed January 1, 2014. http://https://www.inkling.com/read/pharm-phys-anesthetic-practice-stoelting-4th/chapter-10/ch10-section-2.
18. Tune L.E. Anticholinergic effects of medication in elderly patients. JClin Psychiatry 2001, 62(Suppl 21):11-14.
19. Hanlon J.T., Schmader K.E., Koronkowski M.J., et al. Adverse drug events in high risk older outpatients. JAm Geriatr Soc 1997, 45(8):945-948.
20. AGS Beers criteria for potentially inappropriate medication use in older adults. Available at: . Accessed January 1, 2014. http://www.americangeriatrics.org/files/documents/beers/PrintableBeersPocketCard.pdf.
21. Navazesh M., Christensen C., Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. JDent Res 1992, 71(7):1363-1369.
22. Sreebny L. Saliva-salivary gland hypofunction (SGH). FDI Working Group 10. JDent Assoc S Afr 1992, 47(11):498-501.
23. Amerongen A.V., Veerman E.C. Saliva-the defender of the oral cavity. Oral Dis 2002, 8:12-22.
24. Vissink A., Spijkervet F.K., Van Nieuw Amerongen A. Aging and saliva: a review of the literature. Spec Care Dentist 1996, 16(3):95-103.
25. Available at: . Accessed July 28, 2014. http://www.umaryland.edu/medmanagement/anticholinergic.
26. Fox P.C. Dry mouth: managing the symptoms and providing effective relief. JClin Dent 2006, 17(2):27-29.
27. Turner M.D., Ship J.A. Dry mouth and its effects on the oral health of elderly people. JAm Dent Assoc 2007, 138(Suppl):15S-20S.
28. Sreebny L.M., Schwartz S.S. Areference guide to drugs and dry mouth-2nd edition. Gerodontology 1997, 14:33-47.
29. Featherstone J.D. Dental caries: a dynamic disease process. Aust Dent J 2008, 53(3):286-291.
30. Slavkin H.C. Maturity and oral health: live longer and better. JAm Dent Assoc 2000, 131(6):805-808.
31. Charone S., Portela M., das Chagas M., et al. Biofilm of Candida albicans from oral cavity of an HIV-infected child: challenge on enamel microhardness. Oral Surg Oral Med Oral Pathol Oral Radiol 2013, 115(4):500-504. 10.1016/j.oooo.2012.11.003.
32. Signoretto C., Burlacchini G., Faccioni F., et al. Support for the role of Candida spp. in extensive caries lesions of children. New Microbiol 2009, 32(1):101-107.
33. Singh ML, Kugel G, Papas A, etal. Non-carious lesions due to tooth surface loss: to restore or not to restore? Available at: . Inside Dentistry. 2011. Accessed July 28, 2014. http://cdeworld.com/courses/4496.
34. Tabak L.A., Levine M.J., Mandel I.D., et al. Role of salivary mucins in the protection of the oral cavity. JOral Pathol 1982, 11(1):1-17.
35. Moreira T.S., Takakura A.C., Colombari E., et al. Central moxonidine on salivary gland blood flow and cardiovascular responses to pilocarpine. Brain Res 2003, 987:155-163.
36. Kondo Y., Nakamoto T., Mukaibo T., et al. Cevimeline induced monophasic salivation from the mouse submandibular gland: decreased Na+ content in saliva results from specific and early activation of Na+/H+ Exchange. JPharmacol Exp Ther 2011, 337:267-274.
37. Ono K., Inagaki T., Iida T., et al. Distinct effects of cevimeline and pilocarpine on salivary mechanisms, cardiovascular response and thirst sensation in rats. Arch Oral Biol 2012, 57(4):421-428. 10.1016/j.archoralbio.2011.09.013.
38. Dodds M.W., Hsieh S.C., Johnson D.A. The effect of increased mastication by daily gum-chewing on salivary gland output and dental plaque acidogenicity. JDent Res 1991, 70(12):1474-1478.
39. Furness S., Worthington H.V., Bryan G., et al. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev 2011, (12). CD008934. 10.1002/14651858.CD008934.pub2.
40. Ribelles Llop M., Guinot Jimeno F., Mayné Acién R., et al. Effects of xylitol chewing gum on salivary flow rate, pH, buffering capacity and presence of Streptococcus mutans in saliva. Eur J Paediatr Dent 2010, 11(1):9-14.
41. Aguirre-Zero O., Zero D.T., Proskin H.M. Effect of chewing xylitol chewing gum on salivary flow rate and the acidogenic potential of dental plaque. Caries Res 1993, 27:55-59.
42. Miake Y., Saeki Y., Takahashi M., et al. Remineralization effects of xylitol on demineralized enamel. JElectron Microsc (Tokyo) 2003, 52(5):471-476.
43. Bader J.D., Vollmer W.M., Shugars D.A., et al. Results from the Xylitol Adult Caries Trial (X-ACT). J Am Dent Assoc 2013, 144(1):21-30.
44. Johansen E., Papas A., Fong W., et al. Remineralization of carious lesions in elderly patients. Gerodontics 1987, 3(1):47-50.
45. Singh M.L., Papas A.S. Long-term clinical observation of dental caries in salivary hypofunction patients using a supersaturated calcium-phosphate remineralizing rinse. JClin Dent 2009, 20(3):87-92.
46. Weyant R.J., Tracy S.L., Anselmo T.T., et al. Topical fluoride for caries prevention: executive summary of the updated clinical recommendations and supporting systematic review. JAm Dent Assoc 2013, 144(11):1279-1291.